Progress in Anti-Mammarenavirus Drug Development

Mammarenaviruses are prevalent pathogens distributed worldwide, and several strains cause severe cases of human infections with high morbidity and significant mortality. Currently, there is no FDA-approved antiviral drugs and vaccines against mammarenavirus and the potential treatment option is limi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yu-Jin, Venturini, Victor, de la Torre, Juan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310104/
https://www.ncbi.nlm.nih.gov/pubmed/34206216
http://dx.doi.org/10.3390/v13071187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310104/
https://www.ncbi.nlm.nih.gov/pubmed/34206216
http://dx.doi.org/10.3390/v13071187

Ejemplares similares